Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan 12:13:3.
doi: 10.1186/1471-2296-13-3.

COPD exacerbations in general practice: variability in oral prednisolone courses

Marianne de Vries  1 , Annette J Berendsen, Henk E P Bosveld, Huib A M Kerstjens, Thys van der Molen
Affiliations

COPD exacerbations in general practice: variability in oral prednisolone courses

Marianne de Vries et al. BMC Fam Pract. .

Abstract

Background: The use of oral corticosteroids as treatment of COPD exacerbations in primary care is well established and evidence-based. However, the most appropriate dosage regimen has not been determined and remains controversial. Corticosteroid therapy is associated with a number of undesirable side effects, including hyperglycaemias, so differences in prescribing might be relevant. This study examines the differences between GPs in dosage and duration of prednisolone treatment in patients with a COPD exacerbation. It also investigates the number of general practitioners (GPs) who adjust their treatment according to the presence of diabetic co-morbidity.

Methods: Cross-sectional study among 219 GPs and 25 GPs in training, located in the Northern part of the Netherlands.

Results: The response rate was 69%. Nearly every GP prescribed a continuous dose of prednisolone 30 mg per day. Among GPs there were substantial differences in treatment duration. GPs prescribed courses of five, seven, ten, or fourteen days. A course of seven days was most common. The duration of treatment depended on exacerbation and disease severity. A course of five days was especially prescribed in case of a less severe exacerbation. In a more severe exacerbation duration of seven to fourteen days was more common. Hardly any GP adjusted treatment to the presence of diabetic co-morbidity.

Conclusion: Under normal conditions GPs prescribe prednisolone quite uniformly, within the range of the current Dutch guidelines. There is insufficient guidance regarding how to adjust corticosteroid treatment to exacerbation severity, disease severity and the presence of diabetic co-morbidity. Under these circumstances, there is a substantial variation in treatment duration.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Most common treatment regimens for COPD patients without diabetes.
Figure 2
Figure 2
Most common treatment regimens for COPD patients with diabetes.
See this image and copyright information in PMC

References

    1. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lungfunction decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847–852. doi: 10.1136/thorax.57.10.847. - DOI - PMC - PubMed
    1. Walters JAE, Gibson PG, Wood-Baker R, Hannay M, Walters EH. Systemic corticosteroids for acute exacerbations of chronic pulmonary disease. Cochrane Database Syst Rev. 2009;21:CD001288. - PubMed
    1. Bathoorn E, Kerstjens H, Postma D, Timens W, MacNee W. Airways inflammation and treatment during acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:217–229. - PMC - PubMed
    1. Vondracek S, Hemstreet BA. Retrospective evaluation of systemic corticosteroids for the management of acute exacerbations of chronic obstructive pulmonary disease. Am J Helath Syst Pharm. 2006;63:645–652. doi: 10.2146/ajhp050316. - DOI - PubMed
    1. Smeele IJM, Van Weel C, Van Schayck CP, Van der Molen T, Thoonen B, Schermer T. et al.NHG-Standaard COPD. Huisarts Wet. 2007;50:362–379.

MeSH terms